Rat Modeling for GABA Defects in Schizophrenia

Advances in Pharmacology

Volumn 54, Issue , 2006, Pages 73-93

  Benes, Francine M ^a   Gisabella, Barbara ^b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR;

ANIMAL; BRAIN; DISEASE MODEL; HUMAN; LONG TERM POTENTIATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEIN BINDING; RAT; REVIEW; SCHIZOPHRENIA;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; HUMANS; LONG-TERM POTENTIATION; PROTEIN BINDING; RATS; RECEPTORS, GABA; SCHIZOPHRENIA;

EID: 33846132619     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(06)54004-9     Document Type: Review

References (99)

1. Abe K. Modulation of hippocampal long-term potentiation by the amygdala: A synaptic mechanism linking emotion and memory. Jpn. J. Pharmacol. 86 (2001) 18-22
2. Aggleton J.P. A description of the amygdalo-hippocampal interconnections in the macaque monkey. Exp. Brain Res. 64 (1986) 515-526
3. Akbarian S., Kim J.J., Potkin S.G., Hagman J.O., Tafazzoli A., Bunney W.E., and Jones E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52 (1995) 258-278
4. Akirav I., and Richter-Levin G. Biphasic modulation of hippocampal plasticity by behavioral stress and basolateral amygdala stimulation in the rat. J. Neurosci. 19 (1999) 10530-10535
5. Akirav I., and Richter-Levin G. Mechanisms of amygdala modulation of hippocampal plasticity. J. Neurosci. 22 (2002) 9912-9921
6. Alreja M., Wu M., Liu W., Atkins J.B., Leranth C., and Shanabrough M. Muscarinic tone sustains impulse flow in the septohippocampal GABA but not cholinergic pathway: Implications for learning and memory. J. Neurosci. 20 (2000) 8103-8110
7. Altschuler L.L., Conrad A., Kovelman J., and Scheibel A. Hippocampal pyramidal cell orientation in schizophrenia. A controlled neurohistology study of the Yakovlev collection. Arch. Gen. Psychiat. 44 (1987) 1689-1701
8. Anagnostaras S.G., Murphy G.G., Hamilton S.E., Mitchell S.L., Rahnama N.P., Nathanson N.M., and Silva A.J. Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat. Neurosci. 6 (2003) 51-58
9. Antoniadis E.A., and McDonald R.J. Amygdala, hippocampus and discriminative fear conditioning to context. Behav. Brain Res. 108 (2000) 1-19
10. Arnold S.E. "Hippocampal Pathology," (2000), Oxford University Press, Oxford, UK 57-80
11. Arnold S.E., Franz B.R., Gur R.C., Gur R.E., Shapiro R.M., Moberg P.J., and Trojanowski J.Q. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am. J. Psychiatry 152 (1995) 738-748
12. Baldessarini R.J., Hegarty J.D., Bird E.D., and Benes F.M. Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia. Am. J. Psychiatry 154 (1997) 861-863
13. Benes F., and Coyle J.T. Deja vu all over again. Biol. Psychiatry 43 (1998) 781-782
14. Benes F.M. Post-mortem structural analyses of schizophrenic brain: Study designs and the interpretation of data. Psychiatr. Dev. 6 (1988) 213-226
15. Benes F.M. Evidence for neurodevelopment disturbances in anterior cingulate cortex of post-mortem schizophrenic brain. Schizophr. Res. 5 (1991) 187-188
16. Benes F.M. Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophr. Bull. 19 (1993) 537-549
17. Benes F.M. Alterations of neural circuitry within layer II of anterior cingulate cortex in schizophrenia. J. Psychiatr. Res. 33 (1999) 511-512
18. Benes F.M. Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Brain Res. Rev. 31 (2000) 251-269
19. Benes F.M. Carlsson and the discovery of dopamine. Trends Pharmacol. Sci. 22 (2001) 46-47
20. Benes F.M., and Bird E.D. An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Arch. Gen. Psychiatry 44 (1987) 608-616
21. Benes F.M., and Berretta S. Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia. Ann. NY Acad. Sci. 911 (2000) 293-304
22. Benes F.M., and Berretta S. Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia. Ann. NY Acad. Sci. 911 (2000) 293-304
23. Benes F.M., and Berretta S. GABAergic interneurons: Implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25 (2001) 1-27
24. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., and Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 48 (1991) 996-1001
25. Benes F.M., Sorensen I., Vincent S.L., Bird E.D., and Sathi M. Increased density of glutamate-immunoreactive vertical processes in superficial laminae in cingulate cortex of schizophrenic brain. Cereb. Cortex 2 (1992) 503-512
26. A receptor binding in superficial layers of cingulate cortex in schizophrenics. J. Neurosci. 12 (1992) 924-929
27. A receptor binding in the hippocampal formation of schizophrenic brain. Synapse 22 (1996) 338-349
28. Benes F.M., Todtenkopf M.S., and Taylor J.B. Differential distribution of tyrosine hydroxylase fibers on small and large neurons in layer II of anterior cingulate cortex of schizophrenic brain. Synapse 25 (1997) 80-92
29. Benes F.M., Kwok E.W., Vincent S.L., and Todtenkopf M.S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives (see comments). Biol. Psychiatry 44 (1998) 88-97
30. Benes F.M., Todtenkopf M.S., Logiotatos P., and Williams M. Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain. J. Chem. Neuroanat. 20 (2000) 259-269
31. Benes F.M., Vincent S.L., and Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol. Psychiatry 50 (2001) 395
32. Benes F.M., Todtenkopf M.S., and Kostoulakos P. GluR5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives. Hippocampus 11 (2001) 482-491
33. Benes F.M., Burke R.E., Walsh J., Berretta S., Matzilevich D., Minns M., and Konradi C. Acute amygdalar activation induces an upregulation of multiple monoamine G protein coupled pathways in rat hippocampus. Mol. Psychiatry 9 (2004) 895 932-945
34. Berretta S., Munno D.W., and Benes F.M. Amygdalar activation alters the hippocampal GABA system: "Partial" modelling for postmortem changes in schizophrenia. J. Comp. Neurol. 431 (2001) 129-138
35. Berretta S., Lange N., Bhattacharyya S., Sebro R., Garces J., and Benes F.M. Long-term effects of amygdala GABA receptor blockade on specific subpopulations of hippocampal interneurons. Hippocampus 14 (2004) 876-894
36. Birdsall N.J., Curtis C.A., Eveleigh P., Hulme E.C., Pedder E.K., Poyner D., and Wheatley M. Muscarinic receptor subtypes and the selectivity of agonists and antagonists. Pharmacology 37 Suppl. 1 (1988) 22-31
37. Bogerts B., Meertz E., and Schonfeldt-Bausch R. Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch. Gen. Psychiatry 42 (1985) 784-791
38. Bogerts B., Falkai P., and Tutsch J. Cell numbers in the pallidum and hippocampus of schizophrenics. In: Cea S. (Ed). "Biol. Psychiatry" (1986), Elsevier Press, Amsterdam 1178-1180
39. Bymaster F.P., Shannon H.E., Rasmussen K., DeLapp N.W., Ward J.S., Calligaro D.O., Mitch C.H., Whitesitt C., Ludvigsen T.S., Sheardown M., Swedberg M., Rasmussen T., et al. Potential role of muscarinic receptors in schizophrenia. Life Sci. 64 (1999) 527-534
40. Bymaster F.P., Felder C.C., Tzavara E., Nomikos G.G., Calligaro D.O., and McKinzie D.L. Muscarinic mechanisms of antipsychotic atypicality. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 1125-1143
41. Cheong M.Y., Yun S.H., Mook-Jung I., Joo I., Huh K., and Jung M.W. Cholinergic modulation of synaptic physiology in deep layer entorhinal cortex of the rat. J. Neurosci. Res. 66 (2001) 117-121
42. Costa E., Grayson D.R., and Guidotti A. Epigenetic downregulation of GABAergic function in schizophrenia: Potential for pharmacological intervention?. Mol. Interv. 3 (2003) 220-229
43. Costa E., Davis J.M., Dong E., Grayson D.R., Guidotti A., Tremolizzo L., and Veldic M. A GABAergic cortical deficit dominates schizophrenia pathophysiology. Crit. Rev. Neurobiol. 16 (2004) 1-23
44. Costa E., Guidotti A., and Veldic M. Should allosteric positive modulators of GABA(A) receptors be tested in the treatment of schizophrenia?. Schizophr. Res. 73 (2005) 367-368
45. Davis M., and Shi C. The amygdala. Curr. Biol. 10 (2000) R131
46. de Sevilla D.F., Cabezas C., de Prada A.N., Sanchez-Jimenez A., and Buno W. Selective muscarinic regulation of functional glutamatergic Schaffer collateral synapses in rat CA1 pyramidal neurons. J. Physiol. 545 (2002) 51-63
47. Dean B., Bymaster F.P., and Scarr E. Muscarinic receptors in schizophrenia. Curr. Mol. Med. 3 (2003) 419-426
48. Dolan R.J. Emotion, cognition, and behavior. Science 298 (2002) 1191-1194
49. Eastwood S.L., and Harrison P.J. Detection and quantification of hippocampal synaptophysin messenger RNA in schizophrenia using autoclaved, formalin-fixed, paraffin wax-embedded sections. Neuroscience 93 (1999) 99-106
50. Falkai P., and Bogerts B. Cell loss in the hippocampus of schizophrenics. Eur. Arch. Psychiat. Neurol. Sci. 236 (1986) 154-161
51. Fornari R.V., Moreira K.M., and Oliveira M.G. Effects of the selective M1 muscarinic receptor antagonist dicyclomine on emotional memory. Learn Mem. 7 (2000) 287-292
52. Frey S., Bergado-Rosado J., Seidenbecher T., Pape H.C., and Frey J.U. Reinforcement of early long-term potentiation (early-LTP) in dentate gyrus by stimulation of the basolateral amygdala: Heterosynaptic induction mechanisms of late-LTP. J. Neurosci. 21 (2001) 3697-3703
53. Gisabella B., Bolshakov V.Y., and Benes F.M. Regulation of synaptic plasticity in a schizophrenia model. Proc. Natl. Acad. Sci. USA 102 (2005) 13301-13306
54. Guidotti A., Auta J., Davis J.M., Dong E., Grayson D.R., Veldic M., Zhang X., and Costa E. GABAergic dysfunction in schizophrenia: New treatment strategies on the horizon. Psychopharmacology (Berlin) 180 (2005) 191-205
55. Harrison P.J. The neuropathological effects of antipsychotic drugs. Schizophr. Res. 40 (1999) 87-99
56. Harrison P.J., McLaughlin D., and Kerwin R.W. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia. The Lancet 337 (1991) 450-452
57. Heckers S., Heinsen H., Heinsen Y., and Beckmann H. Cortex, white matter, and basal ganglia in schizophrenia: A volumetric postmortem study. Biol. Psychiatry 29 (1991) 556-566
58. Heckers S., Rauch S.L., Goff D., Savage C.R., Schacter D.L., Fischman A.J., and Alpert N.M. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat. Neurosci. 1 (1998) 318-323
59. Heckers S., Stone D., Walsh J., Shick J., Koul P., and Benes F.M. Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia. Arch. Gen. Psychiatry 59 (2002) 521-529
60. Hyman S.E., and Fenton W.S. Medicine. What are the right targets for psychopharmacology?. Science 299 (2003) 350-351
61. Ikegaya Y., Saito H., and Abe K. The basomedial and basolateral amygdaloid nuclei contribute to the induction of long-term potentiation in the dentate gyrus in vivo. Eur. J. Neurosci. 8 (1996) 1833-1839
62. Jeste D., and Lohr J.B. Hippocampal pathologic findings in schizophrenia. Arch. Gen. Psychiatry 46 (1989) 1019-1024
63. Jones E.G. GABA-peptide neurons in primate cerebral cortex. J. Mind Behav. 8 (1987) 519-536
64. Kerwin R., Patel S., and Meldrum B. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience 39 (1990) 25-32
65. Kerwin R.W., Patel S., Meldrum B.S., Czudek C., and Reynolds G.P. Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia. The Lancet 1 (1988) 583-584
66. Kim J.J., Lee H.J., Han J.S., and Packard M.G. Amygdala is critical for stress-induced modulation of hippocampal long-term potentiation and learning. J. Neurosci. 21 (2001) 5222-5228
67. Kovelman J.A., and Scheibel A.B. A neurohistological correlate of schizophrenia. Biol. Psychiat. 19 (1984) 1601-1621
68. Krettek J.E., and Price J.L. Projections from the amygdaloid complex and adjacent olfactory structures to the entorhinal cortex and to the subiculum in the rat and cat. J. Comp. Neurol. 172 (1977) 723-752
69. Lawrie S.M., and Abukmeil S.S. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br. J. Psychiatry. 172 (1998) 110-120
70. LeDoux J.E. Brain mechanisms of emotion and emotional learning. Curr. Opin. Neurobiol. 2 (1992) 191-197
71. LeDoux J.E. Emotion circuits in the brain (In process citation). Annu. Rev. Neurosci. 23 (2000) 155-184
72. Leung L.S., Shen B., Rajakumar N., and Ma J. Cholinergic activity enhances hippocampal long-term potentiation in CA1 during walking in rats. J. Neurosci. 23 (2003) 9297-9304
73. Levey A.I., Kitt C.A., Simonds W.F., Price D.L., and Brann M.R. Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J. Neurosci. 11 (1991) 3218-3226
74. Levey A.I., Edmunds S.M., Koliatsos V., Wiley R.G., and Heilman C.J. Expression of m1-m4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation. J. Neurosci. 15 (1995) 4077-4092
75. Liao D.L., Hong C.J., Chen H.M., Chen Y.E., Lee S.M., Chang C.Y., Chen H., and Tsai S.J. Association of muscarinic m1 receptor genetic polymorphisms with psychiatric symptoms and cognitive function in schizophrenic patients. Neuropsychobiology 48 (2003) 72-76
76. Liu W., Kumar A., and Alreja M. Excitatory effects of muscarine on septohippocampal neurons: Involvement of M3 receptors. Brain Res. 805 (1998) 220-233
77. Longson D., Deakin J.F., and Benes F.M. Increased density of entorhinal glutamate-immunoreactive vertical fibers in schizophrenia. J. Neural. Transm. 103 (1996) 503-507
78. Marino M.J., Rouse S.T., Levey A.I., Potter L.T., and Conn P.J. Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells. Proc. Natl. Acad. Sci. USA 95 (1998) 11465-11470
79. Mesches M.H., Fleshner M., Heman K.L., Rose G.M., and Diamond D.M. Exposing rats to a predator blocks primed burst potentiation in the hippocampus in vitro. J. Neurosci. 19 (1999) RC18
80. Nakao K., Matsuyama K., Matsuki N., and Ikegaya Y. Amygdala stimulation modulates hippocampal synaptic plasticity. Proc. Natl. Acad. Sci. USA 101 (2004) 14270-14275
81. Pitkanen A., Pikkarainen M., Nurminen N., and Ylinen A. Reciprocal connections between the amygdala and the hippocampal formation, perirhinal cortex, and postrhinal cortex in rat: A review (In process citation). Ann. NY Acad. Sci. 911 (2000) 369-391
82. Porter R.H., Eastwood S.L., and Harrison P.J. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia. Brain Res. 751 (1997) 217-231
83. Rakic P. Neurons in rhesus monkey visual cortex. Systematic relation between time of origin and eventual disposition. Science 183 (1974) 425-427
84. Retaux S., Besson M.J., and Penit-Soria J. Opposing effects of dopamine D2 receptor stimulation on the spontaneous and the electrically evoked release of [3H]GABA on rat prefrontal cortex slices. Neuroscience 42 (1991) 61-71
85. Retaux S., Besson M.J., and Penit-Soria J. Synergism between D1 and D2 dopamine receptors in the inhibition of the evoked release of [3H]GABA in the rat prefrontal cortex. Neuroscience 43 (1991) 323-329
86. Reynolds G.P., Czudek C., and Andrews H.B. Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia. Biol. Psychiatry 27 (1990) 1038-1044
87. Richardson M.P., Strange B.A., and Dolan R.J. Encoding of emotional memories depends on amygdala and hippocampus and their interactions. Nat. Neurosci. 7 (2004) 278-285
88. Selemon L.D., Rajkowska G., and Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry 52 (1995) 805-818 discussion 819-820
89. Smith C.J., Perry E.K., Perry R.H., Candy J.M., Johnson M., Bonham J.R., Dick D.J., Fairbairn A., Blessed G., and Birdsall N.J. Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders. J. Neurochem. 50 (1988) 847-856
90. Swanson L.W., and Petrovich G.D. What is the amygdala? (see comments). Trends Neurosci. 21 (1998) 323-331
91. Todtenkopf M.S., and Benes F.M. Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain. Synapse 29 (1998) 323-332
92. Tsvetkov E., Shin R.M., and Bolshakov V.Y. Glutamate uptake determines pathway specificity of long-term potentiation in the neural circuitry of fear conditioning. Neuron 41 (2004) 139-151
93. Van Hoesen G.W., Morecraft R.J., and Vogt B.A. Connections of the monkey cingulate cortex. Neurobiol. Cingulate Cortex Limbic Thalamus (1993) 249-284
94. Vincent S.L., Adamec E., Sorensen I., and Benes F.M. The effects of chronic haloperidol administration on GABA-immunoreactive axon terminals in rat medial prefrontal cortex. Synapse 17 (1994) 26-35
95. Vogt K.E., and Regehr W.G. Cholinergic modulation of excitatory synaptic transmission in the CA3 area of the hippocampus. J. Neurosci. 21 (2001) 75-83
96. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch. Gen. Psychiatry 44 (1987) 660-669
97. Wu M., Shanabrough M., Leranth C., and Alreja M. Cholinergic excitation of septohippocampal GABA but not cholinergic neurons: Implications for learning and memory. J. Neurosci. 20 (2000) 3900-3908
98. Yun S.H., Cheong M.Y., Mook-Jung I., Huh K., Lee C., and Jung M.W. Cholinergic modulation of synaptic transmission and plasticity in entorhinal cortex and hippocampus of the rat. Neuroscience 97 (2000) 671-676
99. Zaidel D.W., Esiri M.M., and Harrison P.J. Size, shape, and orientation of neurons in the left and right hippocampus: Investigation of normal asymmetries and alterations in schizophrenia. Am. J. Psychiatry 154 (1997) 812-818